MAPT and supranuclear palsy, progressive, 1: Indeed, the tau isoform composition was consistent with CBD and PSP, and most importantly, the degradation products resulting from endogenous proteolysis for these cases were similar, indicating the underlying pathobiology of tau, in contrast to neuroanatomy of degenerative changes, is not different in patients with AOS22.